Galvani Bioelectronics
Galvani, a GSK company, is developing therapies to treat disease through implant-based direct modulation of specific neural signals to organs central in chronic disease.
Year Established: 2016
Stock Ticker:
Exchange:
Locations
Galvani Bioelectronics
South San Francisco CAGalvani, a GSK company, is developing therapies to treat disease through implant-based direct modulation of specific neural signals to organs central in chronic disease.
Galvani Bioelectronics
Upper Providence PAGalvani, a GSK company, is developing therapies to treat disease through implant-based direct modulation of specific neural signals to organs central in chronic disease.
Galvani Bioelectronics
Durham NCGalvani, a GSK company, is developing therapies to treat disease through implant-based direct modulation of specific neural signals to organs central in chronic disease.
